Shengtai Pharmaceutical (SGTI) Inventory Turnover Ratio, from third quarter 2013 to third quarter 2012, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Shengtai Pharmaceutical, Inc.  (SGTI)
 

Shengtai Pharmaceutical Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2013, Shengtai Pharmaceutical's inventory turnover ratio sequentially decreased to 4.16 in the third quarter 2013, unsurprisingly, as the Shengtai Pharmaceutical markets continue to deteriorate, and SGTI's faces growing challenges to bring down its inventories. Shengtai Pharmaceutical's average inventory processing period in the Mar 31 2013 quarter, has increased to 88 days, from 83 days, in the Dec 31 2012 quarter.

Within Healthcare sector 75 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2013, to 325, from total ranking in the second quarter 2013 at 424.

SGTI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Shengtai Pharmaceutical, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SGTI Inventory Turnover Ratio (Mar 31 2013)
III. Quarter		 (Dec 31 2012)
II. Quarter		 (Sep 30 2012)
I. Quarter		 (Jun 30 2012)
IV. Quarter		 (Mar 31 2012)
III. Quarter
Y / Y Inventory Growth 63.01 % 104.97 % 134.7 % 126.31 % -
Y / Y Cost of Sales Growth 28.97 % 49.42 % 19.13 % - -2.52 %
Inventory Turnover Ratio (TTM) 4.16 4.4 4.43 - 8.21
SGTI's Total Ranking # 325 # 424 # 0 # 0 #
Average inventory processing period 88 83 82 - 44
Seq. Inventory Growth 20.51 % 11.72 % 8.91 % 11.16 % 51.54 %
Seq. Cost of Sales Growth -23.72 % 33.03 % - - -11.62 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 6
Healthcare Sector # 76
Overall Market # 325

Inventory Turnover Ratio Statistics
High Average Low
5.05 4.51 4.16
(Jun 30 2012)   (Mar 31 2013)



SGTI Company Profile >> Back to SGTI Efficiency Comparisons >> Compare SGTI Inventory Turnover Ratio to its Competitors

Financial Statements
Shengtai Pharmaceutical's Inventories $ 43 Millions Visit SGTI's Balance sheet
Shengtai Pharmaceutical's Cost of Revenues TTM $ 146 Millions Visit SGTI's Income Statement
What are SGTI's Sales? Visit SGTI's Sales by Segment

Other Inventory Turnover Ratios
Shengtai Pharmaceutical's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SGTI's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SGTI's Competitors
Inventory Turnover Ratio for SGTI's Suppliers
Inventory Turnover Ratio for SGTI's Customers

You may also want to know
SGTI's Sales Growth Rates SGTI's Pe Price to earnings ratio SGTI's Receivables Turnover Ratio SGTI's Stock Quote
SGTI's Net Income Growth Rates SGTI's Ps Price to Sales ratio SGTI's Sales per Employee SGTI's Asset Turnover Ratio
SGTI's Net Margin SGTI's Pb Price to Book ratio SGTI's Financial Strength Ratios SGTI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2013, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2013 Inventories at quarter ending Mar 31 2013
Camp4 Therapeutics Corporation  9.09 $ 123.686  Millions$ 14  Millions
Insulet Corporation  8.91 $ 123.776  Millions$ 14  Millions
Bioxytran Inc   8.62 $ 0.093  Millions$ 0  Millions
Cadence Pharmaceuticals Inc  7.94 $ 43.255  Millions$ 5  Millions
Perspective Therapeutics Inc   7.91 $ 3.276  Millions$ 0  Millions
Kewaunee Scientific Corporation  7.73 $ 94.863  Millions$ 12  Millions
Mit Holding, Inc.  7.68 $ 1.193  Millions$ 0  Millions
Hill rom Holdings Inc   7.65 $ 930.900  Millions$ 122  Millions
Dexcom Inc   7.57 $ 55.692  Millions$ 7  Millions
Patterson Companies Inc   7.18 $ 2,446.443  Millions$ 341  Millions
Bohai Pharmaceuticals Group, Inc.  7.05 $ 25.507  Millions$ 4  Millions
Clearday Inc   6.91 $ 3.345  Millions$ 0  Millions
China Pediatric Pharmaceuticals, Inc.  6.75 $ 3.096  Millions$ 0  Millions
Veru Inc   6.70 $ 11.263  Millions$ 2  Millions
Adynxx, Inc.  6.64 $ 1.851  Millions$ 0  Millions
Nutrastar International Inc.  6.61 $ 8.736  Millions$ 1  Millions
Genmark Diagnostics Inc   6.53 $ 14.987  Millions$ 2  Millions
Inotiv Inc   6.44 $ 10.882  Millions$ 2  Millions
Omnova Solutions Inc  6.38 $ 632.100  Millions$ 99  Millions
Star Equity Holdings Inc   5.81 $ 32.924  Millions$ 6  Millions
Micron Solutions Inc  5.80 $ 17.345  Millions$ 3  Millions
Henry Schein Inc   5.73 $ 6,289.074  Millions$ 1,097  Millions
Steris Plc  5.59 $ 880.639  Millions$ 158  Millions
Chembio Diagnostics Inc   5.50 $ 15.484  Millions$ 3  Millions
Enovis Corp  5.44 $ 2,787.179  Millions$ 512  Millions
West Pharmaceutical Services Inc   5.39 $ 891.200  Millions$ 165  Millions
Strata Skin Sciences Inc  5.34 $ 2.992  Millions$ 1  Millions
Masimo Corp  5.26 $ 250.442  Millions$ 48  Millions
Luna Innovations Inc  5.24 $ 18.125  Millions$ 3  Millions
Biolife Solutions Inc   5.24 $ 4.059  Millions$ 1  Millions

Date modified: 2026-09-08T15:21:55+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.